'New' concrete news for #AVCT!
A third #COVID19 diagnostics collaboration, this one with AIM peers #SKIN and #MWG.
AVCT's Affimer reagents to be used in SKIN's next-generation sensors, which are incorporated into MWG's Microtox water contamination system to detect COVID-19. 1/6
"#MWG's Microtox system, which can detect the presence of contaminating bacteria, virus and toxins, is distributed by MWG and has a global footprint of over 3,000 installations."
"#AVCT's Affimer sensors would be consumable items to be replaced on a roughly monthly basis." 2/6
A welcome surprise for me - although in hindsight, it should not have been. #AVCT has repeatedly alluded to incorporating its Affimers into additional diagnostic platforms for #COVID19.
A few very exciting aspects of this collab:
i) Very near-term, monthly recurring revs... 3/6
...that could remain in place for many years. Akin to a v. high margin, long-term royalty stream.
ii) Another opportunity to showcase the incredible versatility of #AVCT's Affimer technology: it's to be used in a novel - non-human diagnostic - application.
4/6
#AVCT's SP is actually down today - AIM Chaos at its finest. Short-term traders and investors seem only interested in the LFT.
Th LFT will come in due course - but it's absurd how the market refuses to attribute value to anything else until that does come.
5/6
Personally, I think there is real pressure building in #AVCT's SP, as today's news just adds to the Co's #COVID19 antigen tests approaching commercialisation, as well as (likely) ongoing talks for a NAf therapy with a major.
The major rerate draws ever closer. 6/6
Share this Scrolly Tale with your friends.
A Scrolly Tale is a new way to read Twitter threads with a more visually immersive experience.
Discover more beautiful Scrolly Tales like this.